Aktis Oncology, Inc. Common stock (AKTS) — Tangible Net Worth Ratio
Aktis Oncology, Inc. Common stock (AKTS) has a Tangible Net Worth Ratio of 68.5% as of March 2024. This metric is calculated by deducting intangible assets ($13.22 Million) from net assets ($41.91 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Aktis Oncology, Inc. Common stock annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Aktis Oncology, Inc. Common stock Tangible Net Worth Ratio (2013–2023)
This chart shows how Aktis Oncology, Inc. Common stock's Tangible Net Worth Ratio has changed across 19 annual periods from 2013 to 2023. As of March 2024, the ratio stands at 68.5%, reflecting net assets of $41.91 Million with intangible assets of $13.22 Million USD. For live market cap and overall valuation, see market value of Aktis Oncology, Inc. Common stock.
Annual Tangible Net Worth Ratio for Aktis Oncology, Inc. Common stock (2013–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Aktis Oncology, Inc. Common stock from 2013 to 2023, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Aktis Oncology, Inc. Common stock (AKTS) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 82.3% | $86.24 Million | $15.24 Million | $148.92 Million | ▼ -9.0 pp |
| 2022 | 91.3% | $103.43 Million | $8.99 Million | $161.34 Million | ▲ +0.0 pp |
| 2021 | 91.3% | $103.43 Million | $8.99 Million | $161.34 Million | ▼ -8.2 pp |
| 2021 | 99.5% | $117.41 Million | $572.00K | $124.99 Million | ▲ +0.8 pp |
| 2020 | 98.7% | $41.49 Million | $544.00K | $71.43 Million | ▲ +0.0 pp |
| 2020 | 98.7% | $41.49 Million | $544.00K | $71.43 Million | ▲ +0.2 pp |
| 2019 | 98.5% | $25.95 Million | $388.00K | $47.95 Million | ▲ +0.0 pp |
| 2019 | 98.5% | $25.95 Million | $388.00K | $47.95 Million | ▲ +0.4 pp |
| 2018 | 98.1% | $13.85 Million | $264.30K | $29.31 Million | ▲ +0.0 pp |
| 2018 | 98.1% | $13.85 Million | $264.30K | $29.31 Million | ▼ -0.5 pp |
| 2017 | 98.6% | $15.01 Million | $206.53K | $18.09 Million | ▲ +0.0 pp |
| 2017 | 98.6% | $15.01 Million | $206.53K | $18.09 Million | ▲ +1.3 pp |
| 2016 | 97.3% | $2.68 Million | $71.23K | $4.54 Million | ▲ +0.0 pp |
| 2015 | 97.3% | $2.68 Million | $71.23K | $4.54 Million | ▼ -1.9 pp |
| 2015 | 99.3% | $4.19 Million | $31.08K | $4.51 Million | ▲ +0.0 pp |
| 2014 | 99.3% | $4.19 Million | $31.08K | $4.51 Million | ▼ -0.7 pp |
| 2014 | 100.0% | $9.21K | $0.00 | $9.52K | ▲ +0.0 pp |
| 2013 | 100.0% | $8.79K | $0.00 | $9.10K | ▲ +0.0 pp |
| 2013 | 100.0% | $8.79K | $0.00 | $9.10K | — |